• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

    10/27/25 8:30:00 AM ET
    $MED
    Packaged Foods
    Consumer Staples
    Get the next $MED alert in real time by email

    Breakthrough Science Expands Company's Mission Beyond Weight Loss to Address Metabolic Health

    Medifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a new focus on holistic metabolic health. The company introduced Metabolic Synchronization™ — a breakthrough science that reverses metabolic dysfunction with a targeted reset of the body's metabolism. Research shows the company's comprehensive system activates strong and targeted fat burn to improve metabolic health by reducing bad visceral fat, preserving lean mass and protecting muscle. This approach results in quality weight loss that goes beyond the scale, ultimately empowering individuals to reach their health goals.

    The Big Picture: Tackling Metabolic Dysfunction

    With nine in ten U.S. adults metabolically unhealthy*, the country is facing a health crisis. Metabolic health — often misunderstood or overlooked — refers to the body's ability to efficiently convert food into energy, regulate critical body functions and maintain internal balance. Metabolic dysfunction is a state that can often silently slip in and can put the body's metabolic processes under strain, cascading into some of today's most serious health challenges.

    "For decades, we've empowered millions of people to achieve significant weight loss and improve their health," said Dan Chard, Chairman and CEO of Medifast. "What we've discovered through our clinical research and breakthrough insights is that the same science driving our program's weight loss outcomes can go even further — helping unlock a healthier metabolism and promoting overall wellbeing. This focus on metabolic health marks the next evolution in our mission: addressing a wider range of health challenges millions face, from weight loss to enhanced vitality and a longer health span."

    From Weight Loss to Metabolic Health: A Strategic Evolution

    Building on its legacy of transforming lives, Medifast is advancing its approach with Metabolic Synchronization™, a breakthrough science that reverses metabolic dysfunction with a targeted reset of the body's metabolism. This new science leverages years of clinical evidence to deliver results beyond the number on the scale.

    The first step of Metabolic Synchronization™ is quality weight loss. Recent breakthrough research shows the company's comprehensive system activates strong and targeted fat burn, driving measurable improvements in overall metabolic health and body composition through three key mechanisms:

    • Burn: Targets visceral fat — the bad fat stored around organs and muscles — achieving a 14% reduction in visceral fat in just 16 weeks**.
    • Preserve: Helps retain 98% of lean mass, supporting strength, energy and mobility during weight loss**.
    • Protect: Supports healthy muscle to help restore the body's natural ability to improve an active metabolism, optimize energy use and regulate body weight.

    "Metabolic health is the foundation of lifelong vitality," said Dr. Satya Jonnalagadda, Vice President of Scientific & Clinical Affairs at Medifast. "Metabolic Synchronization represents an innovative, evidence-based solution that enables people to take control of their health, not just by losing weight, but by improving how their bodies work at a fundamental level."

    Unlocking New Opportunities to Serve Clients Across the Health Journey

    By focusing on the root causes of metabolic dysfunction, Medifast is unlocking new opportunities to reach and empower individuals at every stage of their health journey. For people utilizing weight loss medications, Medifast's programs provide complementary solutions to enhance metabolic function and overall health. For those pursuing a medication-free approach, the company's science-backed system offers an effective alternative, delivering measurable results through its holistic focus on metabolic health.

    Backed by Science, Driven by Innovation and Connection

    With over 40 years of industry leadership, supported by 30+ peer-reviewed publications and clinical studies, Medifast remains committed to advancing science and innovation. The company's structured programs remain integral to this evolution, providing clients with a trusted foundation for metabolic health.

    Medifast also continues to stand apart with its human-centered approach. Clients who work with a personal coach experience 10 times greater weight loss and 17 times greater fat loss than those pursuing self-directed approaches†. Looking ahead, the company plans to launch new products using the science of metabolic synchronization in 2026, incorporating next-generation ingredients that further enhance metabolic health.

    "We've always been about innovation," said Chard. "With Metabolic Synchronization, we're taking the next bold step in our journey. This breakthrough science gives us the opportunity to serve more people in more ways, offering meaningful, evidenced based solutions that adapt to every stage of the health journey. As we look to the future, this scientific breakthrough will serve as the foundation for future innovations that improve lives, restore vitality and redefine what's possible in health and wellness."

    About Medifast

    Medifast (NYSE:MED) is the health and wellness company known for its science-backed, coach-guided lifestyle system. Designed to help address the challenges of metabolic dysfunction, the company's holistic approach integrates personalized plans, scientifically developed products and a framework for habit creation — all supported by a dedicated network of independent coaches. Driven to improve metabolic health through advanced science and comprehensive behavioral support, Medifast has introduced Metabolic Synchronization™, a breakthrough science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. Research shows the company's comprehensive system activates strong and targeted fat burn to enhance metabolic health and body composition by reducing visceral fat, preserving lean mass and protecting muscle. Backed by more than 40 years of clinical heritage, Medifast continues to advance its mission of Lifelong Transformation, Making Healthy Lifestyle Second Nature®. For more information, visit MedifastInc.com, and follow Medifast on X and LinkedIn.

    *O'Hearn M et al. Trends and Disparities in Cardiometabolic Health Among U.S. Adults, 1999-2018. J Am Coll Cardiol. 2022; 80(2):138-151. doi:10.1016/j.jacc.2022.04.046

    **In a clinical study, 98% of lean mass was retained and individuals experienced a reduction of 14% visceral adiposity [visceral fat] on the Optimal Weight 5 & 1 Plan® at 16 weeks. Arterburn LM, et al. Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obes Sci Pract. 2018;5(1):3-14. doi: 10.1002/osp4.312.

    †Those on the Optimal Weight 5&1 Plan® with support of an OPTAVIA Coach successfully lost 10x more weight and 17x more fat than those who tried to lose weight on their own. Arterburn LM, et al. Randomized controlled trial assessing two commercial weight loss programs in adults with overweight or obesity. Obes Sci Pract. 2018;5(1):3-14. doi: 10.1002/osp4.312.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251027013875/en/

    Public Relations: Jessica Oring, [email protected]

    Get the next $MED alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MED

    DatePrice TargetRatingAnalyst
    11/5/2024$16.50 → $17.00Underperform → Neutral
    DA Davidson
    6/5/2024$25.00 → $17.50Neutral → Underperform
    DA Davidson
    10/13/2023$82.00Equal-Weight
    Stephens
    11/4/2022$278.00 → $106.00Buy → Neutral
    DA Davidson
    8/4/2022$345.00 → $150.00Buy → Hold
    Jefferies
    2/24/2022$349.00 → $341.00Buy
    DA Davidson
    11/8/2021$395.00 → $349.00Buy
    DA Davidson
    More analyst ratings

    $MED
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Xian Ming

    4 - MEDIFAST INC (0000910329) (Issuer)

    6/26/25 7:06:44 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    Director Schlackman Scott was granted 11,168 shares, increasing direct ownership by 78% to 25,549 units (SEC Form 4)

    4 - MEDIFAST INC (0000910329) (Issuer)

    6/26/25 7:05:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    Director Thomas Andrea B was granted 11,168 shares, increasing direct ownership by 87% to 24,017 units (SEC Form 4)

    4 - MEDIFAST INC (0000910329) (Issuer)

    6/26/25 7:04:28 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    $MED
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Chard Daniel R bought $5,003 worth of shares (381 units at $13.13) (SEC Form 4)

    4 - MEDIFAST INC (0000910329) (Issuer)

    6/17/25 6:20:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    Thomas Andrea B bought $3,471 worth of shares (50 units at $68.89), increasing direct ownership by 0.81% to 6,253 units (SEC Form 4)

    4 - MEDIFAST INC (0000910329) (Issuer)

    11/9/23 8:20:19 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    Hoer Michael A. bought $3,428 worth of shares (50 units at $68.89), increasing direct ownership by 0.60% to 8,375 units (SEC Form 4)

    4 - MEDIFAST INC (0000910329) (Issuer)

    11/9/23 8:20:03 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    $MED
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference

    Company's Clinical Heritage and Leadership in Metabolic Health Highlighted Through Poster Presentations and Expert Contributions Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by unveiling new research findings during ObesityWeek. Hosted by The Obesity Society in Atlanta, Georgia November 4–7, 2025, the annual conference for obesity researchers and clinicians centers on the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention and the latest efforts

    11/13/25 4:30:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    Medifast Announces Third Quarter 2025 Financial Results

    Medifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. Third Quarter 2025 Revenue: $89.4 million, with revenue per active earning coach of $4,585 Active Coaches: Independent active earning OPTAVIA® coaches of 19,500 Net Loss: $2.3 million or $0.21 loss per diluted share Strong Balance Sheet: $173.5 million in cash, cash equivalents, and investment securities with no debt "We're transforming Medifast from a weight-loss company into a leader in promoting metabolic health," said Dan Chard, Chairman and Chief Executive Officer of Medifast. "Our clini

    11/3/25 4:05:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™

    Breakthrough Science Expands Company's Mission Beyond Weight Loss to Address Metabolic Health Medifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a new focus on holistic metabolic health. The company introduced Metabolic Synchronization™ — a breakthrough science that reverses metabolic dysfunction with a targeted reset of the body's metabolism. Research shows the company's comprehensive system activates strong and targeted fat burn to improve metabolic health by reducing bad visceral fat, preserving lean mass and protecting muscle. This approach results in quality weight los

    10/27/25 8:30:00 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    $MED
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by MEDIFAST INC

    SCHEDULE 13G - MEDIFAST INC (0000910329) (Subject)

    11/13/25 1:37:17 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    SEC Form 10-Q filed by MEDIFAST INC

    10-Q - MEDIFAST INC (0000910329) (Filer)

    11/3/25 4:51:10 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    MEDIFAST INC filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MEDIFAST INC (0000910329) (Filer)

    11/3/25 4:15:23 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    $MED
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Medifast upgraded by DA Davidson with a new price target

    DA Davidson upgraded Medifast from Underperform to Neutral and set a new price target of $17.00 from $16.50 previously

    11/5/24 7:48:00 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    Medifast downgraded by DA Davidson with a new price target

    DA Davidson downgraded Medifast from Neutral to Underperform and set a new price target of $17.50 from $25.00 previously

    6/5/24 7:15:11 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    Stephens initiated coverage on Medifast with a new price target

    Stephens initiated coverage of Medifast with a rating of Equal-Weight and set a new price target of $82.00

    10/13/23 7:41:39 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    $MED
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by MEDIFAST INC

    SC 13G/A - MEDIFAST INC (0000910329) (Subject)

    7/10/24 1:14:41 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    SEC Form SC 13G filed by MEDIFAST INC

    SC 13G - MEDIFAST INC (0000910329) (Subject)

    7/1/24 4:18:04 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    SEC Form SC 13G/A filed by MEDIFAST INC (Amendment)

    SC 13G/A - MEDIFAST INC (0000910329) (Subject)

    2/13/24 10:36:09 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    $MED
    Financials

    Live finance-specific insights

    View All

    Medifast Announces Third Quarter 2025 Financial Results

    Medifast (NYSE:MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. Third Quarter 2025 Revenue: $89.4 million, with revenue per active earning coach of $4,585 Active Coaches: Independent active earning OPTAVIA® coaches of 19,500 Net Loss: $2.3 million or $0.21 loss per diluted share Strong Balance Sheet: $173.5 million in cash, cash equivalents, and investment securities with no debt "We're transforming Medifast from a weight-loss company into a leader in promoting metabolic health," said Dan Chard, Chairman and Chief Executive Officer of Medifast. "Our clini

    11/3/25 4:05:00 PM ET
    $MED
    Packaged Foods
    Consumer Staples

    Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025

    Medifast (NYSE:MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended September 30, 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on November 3, 2025. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or directly

    10/21/25 10:00:00 AM ET
    $MED
    Packaged Foods
    Consumer Staples

    Medifast Announces Second Quarter 2025 Financial Results

    Medifast (NYSE:MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2025. Second Quarter 2025 Revenue: $105.6 million, with revenue per active earning coach of $4,630 Active Coaches: Independent active earning OPTAVIA coaches of 22,800 Net Income: $2.5 million or $0.22 per diluted share, which includes a gain on investment in LifeMD (NASDAQ:LFMD) common stock of $2.0 million (net of tax) Strong Balance Sheet: $162.7 million in cash, cash equivalents, and investment securities with no debt "We are working diligently to transform our business as we look to he

    8/4/25 4:05:00 PM ET
    $LFMD
    $MED
    Medical/Nursing Services
    Health Care
    Packaged Foods
    Consumer Staples

    $MED
    Leadership Updates

    Live Leadership Updates

    View All

    KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, June 7, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from the S

    6/7/24 6:09:00 PM ET
    $ADTN
    $ALTR
    $ATNI
    Telecommunications Equipment
    Utilities
    Computer Software: Prepackaged Software
    Technology

    Medifast Appoints Steven Zenker as Vice President of Investor Relations

    BALTIMORE, March 2, 2023 /PRNewswire/ -- Medifast (NYSE:MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, today announced it has named Steven Zenker as Vice President of Investor Relations. Mr. Zenker has over 30 years of investor relations, financial planning and analysis, communications, and investment management experience. He reports to Chief Financial Officer Jim Maloney and will lead the strategy and continued implementation of the company's investor relations program. "We are pleased to welcome Steven to the Medifast t

    3/2/23 8:30:00 AM ET
    $MED
    Packaged Foods
    Consumer Staples